Vision / Strategy

Grünenthal employees' world-wide aim to make an integral and comprehensive contribution to restoring health and improving the quality of life. In implementing this task we set high standards with regard to quality, effectiveness, safety and environmental compatibility. Grünenthal's international success is based on three pillars: innovation through research, cooperation and growth-orientation.

Research and Development

In recent years Grünenthal has made considerable investments in research and development. Our research and development strategy is aimed at selected indications and the latest technological developments. We are intensively searching for new ways of improving pain relief and reducing side-effects.

Cooperation

International cooperation with other companies and institutions enhances Grünenthal's continuous success. Together with highly specialised partners we are pressing on with the development, production and marketing of our products. One of our special fields of competence is improving known effective analgesics (pain-killers) by modifying the dosage form. One result of these intensive development activities is the matrix patch for the treatment of moderate to severe pain.

Growth

Grünenthal has companies in 32 countries and is seeking to expand its presence in Europe by means of further internationalisation. We have production sites in six countries to supply the world market. In this way Grünenthal markets its products all over the world. At the same time we in-license products in traditional indications and out-license our own successful developments. Grünenthal employs more than 1,900 people in Germany and more than 5,300 people world-wide. Grünenthal products are available in more than 100 countries.